REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $498,378 | -39.9% | 18,005 | -57.2% | 0.23% | -51.2% |
Q3 2022 | $829,000 | +105.7% | 42,056 | +103.3% | 0.47% | +94.7% |
Q2 2022 | $403,000 | -38.0% | 20,685 | -12.5% | 0.24% | -43.5% |
Q3 2021 | $650,000 | -18.2% | 23,637 | -5.6% | 0.43% | -23.8% |
Q2 2021 | $795,000 | +1.9% | 25,038 | +47.4% | 0.56% | -2.8% |
Q1 2021 | $780,000 | – | 16,992 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |